Status:
COMPLETED
Efficacy of Sambucol in the Treatment of Influenza
Lead Sponsor:
Hadassah Medical Organization
Collaborating Sponsors:
Razei Bar industries Ltd.
Conditions:
Influenza
Eligibility:
FEMALE
20-65 years
Phase:
PHASE4
Brief Summary
The trial will examine the efficacy of sambucol in the treatment of influenza. The primary efficacy endpoint will be the length of time to resolution of influenza illness.The double blind trial will b...
Detailed Description
The trial will be conducted at the Personnel Clinic, and at the Clinical virology Unit, Hadassah University Hospital. Candidates for participation in the trial : Patients who will present at the cli...
Eligibility Criteria
Inclusion
- Fever ≥ 380C.
- The presence of at least one of the following respiratory symptoms: cough, sore throat, nasal congestion/ runny nose.
- The presence of at least one of the following systemic symptoms: headache, fatigue, myalgia, chills/sweats, malaise.
Exclusion
- Pregnant women or women who cannot exclude pregnancy.
- Patients with diabetes.
- Immune-suppressed patients, including patients taking immunosuppressive drugs.
- Patients with renal failure.
- Patients who received the recent influenza vaccine.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00375115
Start Date
September 1 2006
End Date
September 1 2009
Last Update
June 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel, 91120